Medy-Tox Inc.
Biopharmaceutical firm developing botulinum toxins, HA fillers, and dermocosmetics.
086900 | KO
Overview
Corporate Details
- ISIN(s):
- KR7086900008
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 청원군 오창읍 각리1길 78 (주)메디톡스, 청원군
- Sector:
- Manufacturing
Description
Medy-Tox Inc. is a biopharmaceutical company focused on the research, development, and commercialization of biologic products. Its primary offerings are centered on botulinum toxin type A (BTX-A) formulations, including Neuronox®, INNOTOX®, Coretox®, and NEWLUX®, which are used for both aesthetic and therapeutic applications. The company is noted for developing the world's first liquid-injectable botulinum toxin. In addition to its toxin portfolio, Medy-Tox manufactures and markets a line of hyaluronic acid (HA) dermal fillers, such as Neuramis®, Atiere, and Potenfill. The company's product range also extends to dermocosmetics under the NEURADERM brand.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.7 KB | ||
| 2024-02-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.7 KB | ||
| 2024-02-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.7 KB | ||
| 2024-02-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.7 KB | ||
| 2024-02-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.7 KB | ||
| 2024-02-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.7 KB | ||
| 2024-02-06 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.5 KB | ||
| 2024-01-22 00:00 |
자기주식처분결과보고서
|
Korean | 17.9 KB | ||
| 2024-01-17 00:00 |
주요사항보고서(자기주식처분결정)
|
Korean | 65.1 KB | ||
| 2024-01-10 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.1 KB | ||
| 2023-12-27 00:00 |
투자판단관련주요경영사항(비동물성 액상형 보툴리눔톡신제제, 미국 FDA 품목 허가 신청(BLA))
|
Korean | 7.9 KB | ||
| 2023-12-26 00:00 |
소송등의제기ㆍ신청(일정금액이상의청구)
|
Korean | 9.0 KB | ||
| 2023-12-14 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.3 KB | ||
| 2023-11-23 00:00 |
투자판단관련주요경영사항(제조판매중지명령 및 품목허가취소등 취소 소송의 각 1심판결에 대한 상대방(피고) 항소의 건)
|
Korean | 9.9 KB | ||
| 2023-11-13 00:00 |
분기보고서 (2023.09)
|
Korean | 1.6 MB |
Automate Your Workflow. Get a real-time feed of all Medy-Tox Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medy-Tox Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medy-Tox Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
